These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 22284448)
1. Characterizing N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) binding for lead poisoning treatment. Chen W; Ercal N; Huynh T; Volkov A; Chusuei CC J Colloid Interface Sci; 2012 Apr; 371(1):144-9. PubMed ID: 22284448 [TBL] [Abstract][Full Text] [Related]
2. Antioxidant and free radical scavenging properties of N-acetylcysteine amide (NACA) and comparison with N-acetylcysteine (NAC). Ates B; Abraham L; Ercal N Free Radic Res; 2008 Apr; 42(4):372-7. PubMed ID: 18404536 [TBL] [Abstract][Full Text] [Related]
3. Quantitation of free and total N-acetylcysteine amide and its metabolite N-acetylcysteine in human plasma using derivatization and electrospray LC-MS/MS. King B; Vance J; Wall GM; Shoup R J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1109():25-36. PubMed ID: 30708342 [TBL] [Abstract][Full Text] [Related]
4. Release of N-acetylcysteine and N-acetylcysteine amide from contact lenses. Atabek Yigit E; Ercal N Eye Contact Lens; 2013 Sep; 39(5):335-40. PubMed ID: 23945523 [TBL] [Abstract][Full Text] [Related]
5. Similarities between N-Acetylcysteine and Glutathione in Binding to Lead(II) Ions. Sisombath NS; Jalilehvand F Chem Res Toxicol; 2015 Dec; 28(12):2313-24. PubMed ID: 26624959 [TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) on glutamate and lead-induced toxicity in CD-1 mice. Penugonda S; Ercal N Toxicol Lett; 2011 Feb; 201(1):1-7. PubMed ID: 21145953 [TBL] [Abstract][Full Text] [Related]
7. Protective effect of N-acetylcysteine on experimental chronic lead nephrotoxicity in immature female rats. Wang L; Wang Z; Liu J Hum Exp Toxicol; 2010 Jul; 29(7):581-91. PubMed ID: 20097726 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic profile of N-acetylcysteine amide and its main metabolite in mice using new analytical method. He R; Zheng W; Ginman T; Ottosson H; Norgren S; Zhao Y; Hassan M Eur J Pharm Sci; 2020 Feb; 143():105158. PubMed ID: 31740394 [TBL] [Abstract][Full Text] [Related]
9. Potentiation of lead-induced cell death in PC12 cells by glutamate: protection by N-acetylcysteine amide (NACA), a novel thiol antioxidant. Penugonda S; Mare S; Lutz P; Banks WA; Ercal N Toxicol Appl Pharmacol; 2006 Oct; 216(2):197-205. PubMed ID: 16781745 [TBL] [Abstract][Full Text] [Related]
10. Effects of N-acetylcysteine amide (NACA), a thiol antioxidant on radiation-induced cytotoxicity in Chinese hamster ovary cells. Wu W; Abraham L; Ogony J; Matthews R; Goldstein G; Ercal N Life Sci; 2008 May; 82(21-22):1122-30. PubMed ID: 18448127 [TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine amide (NACA) prevents retinal degeneration by up-regulating reduced glutathione production and reversing lipid peroxidation. Schimel AM; Abraham L; Cox D; Sene A; Kraus C; Dace DS; Ercal N; Apte RS Am J Pathol; 2011 May; 178(5):2032-43. PubMed ID: 21457933 [TBL] [Abstract][Full Text] [Related]
12. N-Acetylcysteine amide: a derivative to fulfill the promises of N-Acetylcysteine. Sunitha K; Hemshekhar M; Thushara RM; Santhosh MS; Yariswamy M; Kemparaju K; Girish KS Free Radic Res; 2013 May; 47(5):357-67. PubMed ID: 23472882 [TBL] [Abstract][Full Text] [Related]
13. N-acetylcysteine amide and di- N-acetylcysteine amide protect retinal cells in culture via an antioxidant action. Wood JPM; Chidlow G; Wall GM; Casson RJ Exp Eye Res; 2024 Nov; 248():110074. PubMed ID: 39251120 [TBL] [Abstract][Full Text] [Related]
14. Reversal of lead-induced oxidative stress by chelating agent, antioxidant, or their combination in the rat. Tandon SK; Singh S; Prasad S; Srivastava S; Siddiqui MK Environ Res; 2002 Sep; 90(1):61-6. PubMed ID: 12359191 [TBL] [Abstract][Full Text] [Related]
15. Effects of N-acetylcysteine amide (NACA), a novel thiol antioxidant against glutamate-induced cytotoxicity in neuronal cell line PC12. Penugonda S; Mare S; Goldstein G; Banks WA; Ercal N Brain Res; 2005 Sep; 1056(2):132-8. PubMed ID: 16120436 [TBL] [Abstract][Full Text] [Related]
16. Effects of N-Acetylcysteine and N-Acetylcysteine Amide on Erythrocyte Deformability and Oxidative Stress in a Rat Model of Lower Extremity Ischemia-Reperfusion Injury. Erol G; Kartal H; Comu FM; Cetin E; Demirdas E; Sicim H; Unal CS; Gunay C; Oz BS; Bolcal C Cardiol Res Pract; 2020; 2020():6841835. PubMed ID: 33062321 [TBL] [Abstract][Full Text] [Related]
17. Systematic Review of Human and Animal Studies Examining the Efficacy and Safety of Bhatti J; Nascimento B; Akhtar U; Rhind SG; Tien H; Nathens A; da Luz LT Front Neurol; 2017; 8():744. PubMed ID: 29387038 [TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine amide, a promising antidote for acetaminophen toxicity. Khayyat A; Tobwala S; Hart M; Ercal N Toxicol Lett; 2016 Jan; 241():133-42. PubMed ID: 26602168 [TBL] [Abstract][Full Text] [Related]
19. In vivo inhibition of l-buthionine-(S,R)-sulfoximine-induced cataracts by a novel antioxidant, N-acetylcysteine amide. Carey JW; Pinarci EY; Penugonda S; Karacal H; Ercal N Free Radic Biol Med; 2011 Mar; 50(6):722-9. PubMed ID: 21172425 [TBL] [Abstract][Full Text] [Related]
20. Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro. Gillissen A; Jaworska M; Orth M; Coffiner M; Maes P; App EM; Cantin AM; Schultze-Werninghaus G Respir Med; 1997 Mar; 91(3):159-68. PubMed ID: 9135855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]